#VNDA
Vanda Pharmaceuticals ($VNDA) – New 5% holder

• Holder: State Street
• Stake: 0 → 5% (about $12M)
• About 13G: a passive investor, not seeking to influence the company
• Filed: Nov 10 · Schedule 13G

📊 More at www.elixstocks.com

Educational only. Not investment advice.

#Investing #Stocks
State Street Corp: 5% of Vanda Pharmaceuticals ($VNDA)
Schedule 13G filed Nov 10. Who filed, the stake, and how it changed.
elixstocks.com
November 12, 2026 at 12:58 AM
#$VNDA prices are dropping and there is no good news on the near future. We recommend holding to take further losses.
November 12, 2026 at 12:59 PM
@FreakyFwoof Don't worry! I developed a revolutionary new NDVA addon to help! Just install this VNDA addon and it will add proofreading functions to jaws to help you! All you have to do is press voiceover+P and then Narrator will open a dialogue showing all the mistakes AI made so you can […]
Original post on fed.interfree.ca
fed.interfree.ca
November 13, 2026 at 2:00 PM
November 9, 2026 at 6:25 PM
🚨 $VNDA
Duncan Charles Cliff (Insider) bought 10,000 shares at an average price of $3.8094 per common share. (Date: 2026-11-05)
SEC Filing: VNDA
Click to view the official SEC document.
www.sec.gov
November 5, 2026 at 9:35 PM
Vanda Pharmaceuticals ($VNDA) – Insider Purchase

• Insider: Charles Cliff Duncan, Director
• Bought: 10,000 shares (about $38K)
• Price: about $3.81 a share · Nov 3-5
• Now Holds: 108,701 shares directly

📊 More at www.elixstocks.com

Educational only. Not investment advice.

#InsiderBuying #Stocks
Charles Cliff Duncan (Director) bought $38K of Vanda Pharmaceuticals ($VNDA)
Form 4 filed Nov 5. Every line of the filing.
elixstocks.com
November 5, 2026 at 9:34 PM
I looked at the business behind $VNDA (Vanda Pharmaceuticals Inc.) for you. Based on financial data and reported results.

At what market price would buying or selling $VNDA make sense to you?

#VNDA #Vanda
November 3, 2026 at 11:25 PM
HUGE News: Vanda Pharmaceuticals #VNDA), is taking the FDA back to court - fighting to advance truly human-relevant science without suffering. They are calling on scientists and the public to stand with them. We are with you, Vanda!! #thenewgoldstandard #abolishanimaltesting
November 2, 2026 at 5:02 PM
#$VNDA weekly close $3.79 (-5.5% w/w), below SMA50 $4.79 / below SMA200 $6.21, RSI 26.7. Support $3.74, resistance $4.64. Broad market sell-off Friday.

New hub updated: www.merlintrader.com/vanda-pharma...
October 31, 2026 at 8:09 AM
#$VNDA weekly close $3.79 (-5.5% w/w), below SMA50 $4.79 / below SMA200 $6.21, RSI 26.7. Support $3.74, resistance $4.64. Broad market sell-off Friday.

New hub updated: www.merlintrader.com/vanda-pharma...
October 31, 2026 at 8:09 AM
#$VNDA Q3 10-Q (Oct 29): sales $69.8M (+24%), operating loss $23.5M. Close $4.05 (Oct 29), RSI 27, support $3.79, resistance $4.25.
www.merlintrader.com/vanda-pharma...
Vanda ($VNDA): HETLIOZ DSWPD Data, Quimilza PDUFA Dec 12
Vanda Pharmaceuticals ($VNDA) hub: the December 12, 2026 FDA date for Quimilza in GPP, the positive HETLIOZ Phase 3 in DSWPD, cash, burn and the risks.
www.merlintrader.com
October 30, 2026 at 11:35 AM
#$VNDA Q3 10-Q (Oct 29): sales $69.8M (+24%), operating loss $23.5M. Close $4.05 (Oct 29), RSI 27, support $3.79, resistance $4.25.
www.merlintrader.com/vanda-pharma...
Vanda ($VNDA): HETLIOZ DSWPD Data, Quimilza PDUFA Dec 12
Vanda Pharmaceuticals ($VNDA) hub: the December 12, 2026 FDA date for Quimilza in GPP, the positive HETLIOZ Phase 3 in DSWPD, cash, burn and the risks.
www.merlintrader.com
October 30, 2026 at 11:35 AM
$VNDA $4.00 Wed, SMA50 <$4.85 SMA200 <$6.25, bottom 20d ($3.79-$4.96), EMA20 <$4.29, RSI 30.
Q3 revenue $69.8M, diluted EPS -$0.37.
https://justcharts.merlintrader.com/#VNDA
Not investment advice.
October 29, 2026 at 4:02 AM
$VNDA $4.00 Wed, SMA50 <$4.85 SMA200 <$6.25, bottom 20d ($3.79-$4.96), EMA20 <$4.29, RSI 30.
Q3 revenue $69.8M, diluted EPS -$0.37.
https://justcharts.merlintrader.com/#VNDA
Not investment advice.
October 29, 2026 at 4:02 AM
$VNDA Q3 results today after close, call 4:30pm ET (webcast on company IR site).
Tue close $3.99, below SMA50 and SMA200, RSI 30.
Hub: https://www.merlintrader.com/vanda-pharmaceuticals-vnda-stock-hub/
Not investment advice.
Chart: https://justcharts.merlintrader.com/#VNDA
October 28, 2026 at 8:08 AM
🚨 $VNDA
On October 28, 2026, Vanda Pharmaceuticals Inc. issued a press release and is holding a conference call regarding its results of operations and financial condition for the quarter ended September 30, 2026 . The full text of the press release is furnished as Exhibit 99.1 to this Current Re...
SEC Filing: VNDA
Click to view the official SEC document.
www.sec.gov
October 28, 2026 at 8:10 PM
📈Sub-$500M premarket prep — 2026-10-29

#$VNDA — Oct. 28 8-K says Vanda issued a Q3-results press release and held an earnings call.
#$GCTK — Oct. 28 8-K reported its 1-for-2 reverse split became effective Oct. 23; split-adjusted trading began Oct. 26.

Did I miss something?
October 29, 2026 at 7:54 AM
$VNDA — Thetis (3601) positive: tradipitant reduced GLP-1 vomiting 43.0% vs 58.5% placebo (p=0.006).

Information only — not investment advice.

https://www.merlintrader.com/vanda-pharmaceuticals-vnda-stock-hub/
October 27, 2026 at 3:32 PM
Vanda (#$VNDA): NEREUS met its Phase 3 primary endpoint, cutting GLP-1 (semaglutide) vomiting to 43.0% vs 58.5% on placebo (P=0.006). Single non-titrated dose.

prismmarketview.com/vanda-report...
Vanda Reports Positive Phase 3 Results for NEREUS in Preventing GLP-1-Related Vomiting
Key Points Vanda’s NEREUS reduced the proportion of participants who vomited after semaglutide from 58.5% with placebo to 43.0%. The trial met its pri
prismmarketview.com
October 27, 2026 at 3:28 PM
#$VNDA closed at $4.01, below the 50-day EMA ($4.82) and the 200-day ($5.64), near the low of its 20-day range ($3.88-$5.19). Daily RSI 28.

Interactive chart at JC Just Charts: justcharts.merlintrader.com#VNDA
Not investment advice.
JustCharts: Stock Charts & Technical Analysis | Merlintrader
Explore US stock charts with EMA 50 and 200, support, resistance, trendlines and conditional technical scenarios. Daily data from the Merlintrader hub universe.
justcharts.merlintrader.com
October 25, 2026 at 3:39 PM
October 24, 2026 at 4:26 PM